Trump’s Orders Elevate The Medical Status Of Psychedelics And Cannabis – Forbes
Federal policy changes around cannabis and psychedelics create significant federal cannabis rescheduling clinical implications for medical practice. Understanding regulatory shifts helps clinicians navigate evolving treatment landscapes while maintaining…
The Trump administration’s moves on marijuana and psychedelics signal the start of a new …
✦ New CED Clinical Relevance #55 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyResearchMental Health Clinical Summary I don’t have access to the full article content needed to write an…
Classic psychedelic and cannabis use among U.S. cancer survivors aged ≥ 50 years: nationally representative estimates by cancer type/site.
To examine the prevalence of lifetime ("ever") cannabis and classic psychedelic use, and their co-use among U.S. adults aged ≥ 50 years with versus without a...
Brain-Body Integromics of the Ayahuasca Experience
Brain-body integration ayahuasca effects reveal how this psychoactive brew induces coordinated changes across biological systems. This study maps metabolism, brain connectivity, and subjective experience in ayahuasca users. Understanding these effects is…
Amrit Baral: Cannabis and Psychedelic Use Among Older U.S. Cancer Survivors
Psychedelic use older cancer survivors is an emerging area of clinical interest. This article provides estimates that inform screening and safety considerations. Understanding these patterns helps optimize symptom management in older cancer survivors.
Trump psychedelics order largely symbolic, analysts say – The Guardian
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Mental…
Why Veterans Advocate for Looser Psychedelic and Cannabis Research Restrictions
Veterans psychedelic cannabis research highlights the need for looser restrictions to advance treatment options. This research focuses on PTSD and treatment-resistant conditions common among veterans. Looser research restrictions could enable better…
Joshua S. Bauchner Talks Psychedelics & Policy at National Cannabis Research …
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic PolicyPsychedelicsRegulatoryClinical…
Classic psychedelic and cannabis use among U.S. cancer survivors aged ≥ 50 years: nationally representative estimates by cancer type/site.
This study examines classic psychedelic and cannabis use among older cancer survivors aged 50 years and above. It provides nationally representative estimates by cancer type and site. Understanding these patterns is crucial for clinical and policy…
A Review of Trump’s Recent Psychedelic Executive Order – Drug Science
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic PolicyPsychedelicsRegulationAddiction…
